{
  "report_rows": [
    {
      "kpi": "Adj. Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$6.30 vs. cons $5.96",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Behavioral SS Adj. Patient Day Growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~+2.0% vs. cons +1.66%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net Revenues (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4.65B vs. cons $4.587B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adj. Operating EPS (FY2026)",
      "prediction": "BETTER",
      "answer": "guide ~$24.25 midpoint vs. cons $23.52",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net Revenues (FY2026)",
      "prediction": "BETTER",
      "answer": "guide ~$18.80B midpoint vs. cons $18.55B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Behavioral SS Vol. Growth (FY2026)",
      "prediction": "UNCHANGED",
      "answer": "reaffirm 2%-3% range vs. cons ~2.0%",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side H2 estimate revisions catch up to FY raise; partially offset by pre-earnings run being given back",
  "day5_confidence": "MEDIUM"
}